This repository contains the technical documentation for the cost-effectiveness analysis of COVID-19 Vaccination Strategies in the Western Pacific Region
Please cite this as: Carvalho N, Akpan E, Wang Y, Bourke M, Abraham P, McVernon J. Cost-effectiveness Analysis of COVID-19 Vaccination Strategies in the Western Pacific Region: Description of methods, version 1.0, 2023 [27 February]. Available at https://github.com/spectrum-spark/covid-CEA
Correspondence to: [email protected]
The code in this repository was primarily written by Edifofon Akpan and Yingying Wang.
This repository also contains code to conduct cost-effectiveness analysis, as part of work examining cost-effectiveness of boosting allocations
This code here takes in model outputs from epidemic simulations, which are already stored in the /data folder.
Base plots: https://github.com/spectrum-spark/covid-CEA/blob/main/2_Plots_Base.R
Tornado plots (sensitivity analysis): https://github.com/spectrum-spark/covid-CEA/blob/main/3_Plots_DSA.R
To produce the plots in the main paper, run 2_Plots_Paper.R; the plots are saved in /plots folder.
The work in this repository presented to the Advisory Committee on Immunization and Vaccines-related Implementation Research (IVIR-AC) in February 2023. It is also an accompaniment to the following paper and report:
Thao P. Le, Eamon Conway, Edifofon Akpan, Isobel Abell, Patrick Abraham, Christopher M. Baker, Patricia T. Campbell, Deborah Cromer, Michael J. Lydeamore, Yasmine McDonough, Ivo Mueller, Gerard Ryan, Camelia Walker, Yingying Wang, Jodie McVernon and Natalie Carvalho, Cost-effective boosting allocations in the post-Omicron era of COVID-19 management, in preparation, 2023.
Eamon Conway, Thao P. Le, Isobel Abell, Patrick Abraham, Edifofon Akpan, Christopher Baker, Mackenzie Bourke, Patricia T. Campbell, Natalie Carvalho, Deborah Cromer, Alexandra B. Hogan, Michael J. Lydeamore, Yasmine McDonough, Ivo Mueller, Gerald Ryan, Camelia Walker, Yingying Wang, and Jodie McVernon, A flexible immunity model-based framework for evaluation of likely impacts of emerging variants & vaccines: Technical Report, 2023.